Experimental virus therapy for colorectal cancer shows early promise but study halted
Disease control
Terminated
This study tested a new treatment for people with advanced colorectal cancer that did not respond to standard chemotherapy. The treatment combined a virus that attacks cancer cells (oncolytic immunotherapy) with two approved drugs (atezolizumab and bevacizumab). Only 5 people enr…
Phase: PHASE2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Apr 26, 2026 18:54 UTC